Mode
Text Size
Log in / Sign up
N/A Completed N=30 Treatment

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Visual Acuity
Source: ClinicalTrials.gov NCT00759096 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2010
Primary outcomePrimary: Near Uncorrected Visual Acuity(UCVA — 0.5 logMAR

Summary

The purpose of this study is to assess uniocular and binocular unaided distance, intermediate, and near VA; contrast sensitivity, accommodation amplitude, stereopsis, glare testing, ocular aberrations and the clinical satisfaction assessment after bilateral implant of the Restor IOL.

Outcome Measures

OutcomeResultp-value
PRIMARY
Near Uncorrected Visual Acuity(UCVA
0.5
SECONDARY
Contrast Sensitivity

Eligibility Criteria

Inclusion Criteria

  • ≥21 years of either gender or any race
  • Potential post-op VA 20/20
  • Pre-op astigmatism ≤ 1.0D
  • Able to sign the informed consent
  • Able to complete all required postoperative visits
  • Planned cataract removal by phaco
  • Clear intraocular media other than cataract

Exclusion Criteria

  • Signs of capsular tear, significant anterior chamber hyphema, or zonular rupture
  • Any corneal pathology and previous corneal refractive surgery
  • Patients with unrealistic expectations in anticipated post-op VA
  • Happy to wear glasses
  • Occupational night driver
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00759096). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search